Hengrui Pharma Gets China Clinical Trial Approval for 10 Anti-Tumor Drugs MT Sep. 21 Hengrui Pharma Gets Clinical Trial Approval for Chronic Kidney Disease Drug MT Sep. 21 Hengrui Pharmaceuticals Gets ...

Medpace is rated Sell, with a $484.49 fair value versus a $612.05 close—implying a 26.33% premium. Click to read more about ...

Large-scale operational measures were carried out by law enforcement agencies in the city of Chirchik and the Kibray district ...

BJP MP Anurag Thakur attacked the AAP government after anti-drug activist Parvinder Singh Jhota was allegedly shot dead by a ...

Strategic outsourcing, AI, automation and integrated CRO partnerships boost discovery speed, scalability, cost control and customer retention.Dublin, Oct. (GLOBE NEWSWIRE) -- "Drug Discovery Services ...

The legal experts recently discussed the mechanics of direct-to-patient (DTP) and direct-to-employer (DTE) models.

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2025, the Group had a portfolio of 8 ...

Cytokinetics has delivered a sizeable 81.2% share price gain over the past three years, helped by fresh momentum around its ...

Cabaletta Bio is rated Buy, trading 40% below its $2.41 pipeline value despite a single-asset risk profile. Click here to ...

The pharmaceutical industry’s leading trade group is suing the Trump administration over a new Medicare drug-pricing program ...